Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Rina-S earned breakthrough remedy designation from the FDA for sufferers with superior endometrial most cancers whose illness has worsened after platinum-based chemotherapy.The U.S....
Kristen Dahlgren, a breast most cancers survivor who's the founder and CEO of the Most cancers Vaccine Coalition, understands the significance of sufferers...
The FDA granted rusfertide breakthrough remedy designation for sufferers with polycythemia vera.An investigational drug known as rusfertide might quickly supply a brand new...
Dr. Neal Patel says biopsy outcomes might not absolutely seize prostate most cancers danger, stressing that PSA, stage and illness quantity also needs...
